4//SEC Filing
Utterberg David S 4
Accession 0001209191-12-055401
CIK 0001333170other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:47 PM ET
Size
9.3 KB
Accession
0001209191-12-055401
Insider Transaction Report
Form 4
Utterberg David S
Director10% Owner
Transactions
- Sale
Common Stock
2012-11-29$12.13/sh−21,346$258,982→ 4,300,950 total - Sale
Common Stock
2012-11-30$11.99/sh−19,973$239,568→ 4,280,977 total - Sale
Common Stock
2012-12-03$12.06/sh−26,325$317,456→ 4,254,652 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2010, amended on March 11, 2011, and further amended on August 15, 2012.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.22. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.54 to $12.06. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.89 to $12.15. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001341407
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:47 PM ET
- Size
- 9.3 KB